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BRIEF DEFINITIVE REPORT binant material in 50 Etl 0 .1 M borate buffer, pH 8 .5, was added to 1 MCi 125 1-labeled (2, 200 Ci/mmol; monoiodinated) Bolton Hunter reagent, incubated, and fractionated as described (9) . The biological potency ofthe radiolabeled material was checked by assaying myeloperoxidase release from neutrophils as described by Schroder et al . (5) .
Binding of 1251-MDNCF to Neutrophils. Binding of the labeled MDNCF to the intact human neutrophils was carried out as previously described for IL-1 (9) . In standard binding assays, 2 x 106 cells were incubated in duplicate with 4 ng 1251-MDNCF in RPMI 1640 medium with 10 mg/ml BSA in a total volume 200 pl. The nonspecific binding was carried out by parallel incubation in the presence of 80-fold excess of unlabeled MDNCF. Chemical Crosslinking and SDS-PAGE Analysis. For chemical crosslinking experiments, 10' neutrophils suspended in 1 ml RPMI 1640 medium were incubated with 125 1-MDNCF (20 ng) for 1 h at 4°C. Parallel experiments were performed in the presence of unlabeled MDNCF (2,000 ng) in a similar manner. After incubation, the cells were washed twice with 1 ml cold D-PBS and were suspended in 100 pl D-PBS. Then, disuccinimidyl suberate (DSS) at varying concentrations in DMSO was added to give a final concentration of 0 .75, 1, and 1 .25 mg DSS/ml . The mixtures were incubated for 1 h at 4°C . The cells were washed with cold D-PBS twice and suspended in 50 it] D-PBS containing 9 mM CHAPS and 2 tl of the mixture, each containing PMSF (12 .8 ng), leupeptin (16 ng), pepstatin (80 ng), and chymostatin (2 ng) . The detergent extraction mixtures were incubated on ice for 5 min and then centrifuged at 10,000 g for 15 min at 4°C . SDS-PAGE was done as described by Laemmli (10), followed by autoradiography.
Results and Discussion
Radiolabeling of MDNCF. Carrier-free recombinant MDNCF was labeled with Bolton Hunter reagent and chromatographed on a Sephadex column . The radiolabeled MDNCF was homogenous on SDS-PAGE and free of uncoupled Bolton-Hunter reagent (data not shown). The biological activity of the radiolabeled MDNCF was retained as assessed by the measurement of myeloperoxidase release from neutrophils (data not shown). The specific activity of labeled MDNCF was estimated to be 7 x 10' cpm/ug of protein .
Speck Binding of 1251-MDNCF to Neutrophils. As shown in Fig . 1 , excess amount of nonradioactive MDNCF was able to inhibit the binding of 125 1-MDNCF to neutrophils by >95%. This inhibitory effect of unlabeled MDNCF was dose dependent . In contrast, other chemotactic cytokines and agents such as TNF, IL-la, FMLP, LTB4, C5a, and platelet activating factor did not exert significant inhibitory effects on binding of radiolabeled MDNCF to neutrophils, demonstrating specificity of binding of 125 1-MDNCF and establishing that MDNCF receptors are distinct from any other chemotactic cytokine or agent receptors . Scatchard Analysis of MDNCF Receptor. The saturability of binding of 125 1-MDNCF to neutrophils was examined . The total binding of MDNCF increased in proportion to the amount of added labeled material . The specific binding was similarly increased (Fig . 3) and was saturated in the presence of 25 ng 125 1-MDNCF. The nonspecific binding ofMDNCF increased linearly with increasing amounts of radiolabeled ligand . The Scatchard analysis of specific MDNCF binding at 4°C after 3 h showed a curvilinear pattern. The equilibrium Kd was 8 x 10 -1°M, with the number of receptors per neutrophil estimated to be "20,000%ell. This type of curvature and nonlinear Scatchard plot has been obtained in many receptor-ligand interactions (11) . It was determined that the Hill coefficient (nH) was 1.09, indicating no significant positive or negative cooperativity in binding of MDNCF to receptors . Therefore, the MDNCF receptors seem to have single binding affinity.
Chemical Crosslinking of MDNCF with Its Receptor. Chemical crosslinking of MDNCF with its receptor was carried out using a bivalent crosslinking reagent DSS. Fig. 4 presents autoradiographs of SDS-PAGE with three different concentrations of DSS to fractionate the cell extracts under reducing conditions. Two bands of mol wt 75,000 and 67,000 were detected . These signals disappeared in the presence ofexcess unlabeled MDNCF, indicating that the bands represented MDNCFspecific binding molecules . Assuming that one MDNCF molecule binds to one receptor molecule, the molecular weight of MDNCF binding proteins were estimated to be 67,000 and Autoradiograph of chemically crosslinked MDNCF receptor complexes from human neutrophils analyzed by SDS-PAGE (10%). Lanes 1, 3, and 5 present the crosslinked molecules prepared in the absence of unlabeled MDNCF using 0.75, 1, and 1.25 mg/ml DSS, respectively. Lanes 2, 4, and 6 present the same experiment in the presence of an 80-fold excess of unlabeled MDNCF. The molecular weight markers of the standard proteins were also run in SDS-PAGE as indicated in the figure . The results represent three independent experiments . 59,000 . There was no significant difference in migration of the chemically crosslinked receptors on SDS-PAGE under reducing and nonreducing conditions (data not shown) . These two bands may represent noncovalently associated MDNCF receptor subunits, proteolytically cleaved molecules, or posttranslationally modified molecules as by glycosylation, acylation, and phosphorylation.
Increase of MDNCF Receptor Expression on DMSO-treated HL60 Cells. The HL60 human promyelocytic leukemic cell line could be differentiated into myelocytes and metamyelocytes by the addition of 1 .25% DMSO (8) . The binding assay was first carried out using a single saturating amount (4 ng) of 125 1-MDNCF before and after 5 d of incubation with DMSO. In uninduced promyelocytes, the binding of the labeled material was low but was increased by fourfold in the DMSO-treated cells. Scatchard analysis performed at 4°C showed that -7,000 receptors were present per DMSO-treated HL60 cell . The Kd was 1 .2 x 10-9 M, which was similar to the Kd value for the MDNCF receptors on normal peripheral blood neutrophils (data not shown). This indicates that promyelocytes express small numbers of MDNCF receptors and that the expression of the MDNCF receptor increases with each successive stage of maturation of neutrophils, becoming maximal in the mature PMN.
In conclusion, we have reported the detection of an MDNCFspecific receptor that is distinct from the receptors for other known chemoattractants. Purification and further characterization of the MDNCF-specific receptor may provide insights into the mechanism of action of MDNCF.
Summary
Specific receptors for a recently purified and cloned monocyte-derived neutrophil chemotactic factor (MDNCF) have been identified on the surface of normal human peripheral blood neutrophils using 125 I-labeled recombinant human MDNCF 
